Valeria Tovazzi

Outcome of EGFR-mutated adenocarcinoma NSCLC patients with changed phenotype to squamous cell carcinoma after tyrosine kinase inhibitors: A pooled analysis with an additional case.

W. Vermi, Alfredo Berruti, E. Roca, 2019, Lung cancer.